A licensed vaccine against Francisella tularensis is currently not available. Two Francisella tularensis subsp. novicida (herein referred to by its earlier name, Francisella novicida) attenuated strains, the ⌬iglB and ⌬fopC strains, have previously been evaluated as potential vaccine candidates against pneumonic tularemia in experimental animals. F. novicida ⌬iglB, a Francisella pathogenicity island (FPI) mutant, is deficient in phagosomal escape and intracellular growth, whereas F. novicida ⌬fopC, lacking the outer membrane lipoprotein FopC, which is required for evasion of gamma interferon (IFN-␥)-mediated signaling, is able to escape and replicate in the cytosol. To dissect the difference in protective immune mechanisms conferred by these two vaccine strains, we examined the efficacy of the F. novicida ⌬iglB and ⌬fopC mutants against pulmonary live-vaccine-strain (LVS) challenge and found that both strains provided comparable protection in wild-type, major histocompatibility complex class I (MHC I) knockout, and MHC II knockout mice. However, F. novicida ⌬fopC-vaccinated but not F. novicida ⌬iglB-vaccinated perforin-deficient mice were more susceptible and exhibited greater bacterial burdens than similarly vaccinated wild-type mice. Moreover, perforin produced by natural killer (NK) cells and release of granzyme contributed to inhibition of LVS replication within macrophages. This NK cell-mediated LVS inhibition was enhanced with anti-F. novicida ⌬fopC immune serum, suggesting antibody-dependent cell-mediated cytotoxicity (ADCC) in F. novicida ⌬fopC-mediated protection. Overall, this study provides additional immunological insight into the basis for protection conferred by live attenuated F. novicida strains with different phenotypes and supports further investigation of this organism as a vaccine platform for tularemia.
L
ive attenuated vaccines have played a significant role in control of bacterial and viral infections (3, 4, 31, 32, 34, 38, 44) . The immune response to a live attenuated vaccine closely resembles that produced by a natural infection, usually comprising potent cellular and humoral responses (14, 71) . Owing to their relative complex genetic nature, attenuated bacterial vaccines are often difficult to develop despite the availability of molecular techniques (34, 49, 70) . To this end, there is a continued interest in development of a live attenuated vaccine against pneumonic tularemia. Francisella tularensis, the etiological agent of tularemia, is a Gramnegative facultative intracellular bacterium (11, 69) . Untreated cases of pneumonic tularemia caused by the virulent human type A strains (Francisella tularensis subsp. tularensis) may have mortality rates of 30 to 60% (66) . A live vaccine strain (LVS), derived from a type B strain that is less virulent in humans (Francisella tularensis subsp. holarctica), has been used to immunize millions of individuals in the former Soviet Union (62) . However, LVS has not been licensed for general use due to phenotypic inconsistency (12, 23) and a lack of understanding of the nature of attenuation. Recently, our laboratory evaluated vaccine strains derived from Francisella tularensis subsp. novicida (herein referred to by its earlier name, Francisella novicida) (U112 strain) in experimental rodent models and found that protection can be achieved against heterotypic pulmonary LVS and SCHU S4 (type A) bacterial challenge (9, 53) . F. novicida is genetically related to type A F. tularensis [98.1% homology between sequences common to U112 and the type A strain SCHU S4 (55) ] and is avirulent in humans.
Using F. tularensis as a model pathogen, this study aimed at gaining additional immunological insight into the basis for protection conferred by live attenuated bacterial vaccines. Specifically, two live attenuated F. novicida mutant strains, namely, F. novicida ⌬fopC (46) and F. novicida ⌬iglB (9), were directly compared in order to characterize the mechanistic details underlying the respective protective efficacy against pulmonary F. tularensis LVS challenge. F. novicida ⌬iglB is a Francisella pathogenicity island (FPI) mutant, deficient in intramacrophage growth and phagosomal escape (7, 36, 47) . In contrast, F. novicida ⌬fopC has a deficiency in the outer membrane lipoprotein (FopC), which has been reported by us (46) to mediate evasion of gamma interferon (IFN-␥)-mediated signaling and by others (35, 56) to play a role in iron acquisition and to be an important virulence factor for type A F. tularensis. Moreover, F. novicida ⌬fopC replicated similarly to wild-type F. novicida U112 in primary macrophages that had not been stimulated with IFN-␥ (46) , suggesting that the bacterium likely escaped from phagosomes and replicated within the cytosol. Given the difference in phagosomal escape between F. novicida ⌬iglB and F. novicida ⌬fopC, the host may likely utilize different antigen-processing pathways and T-cell subsets to generate protective immunity.
To this end, the major histocompatibility complex class I (MHC I) pathway samples intracellular antigens (such as proteins secreted or degraded from cytosolic F. novicida ⌬fopC bacteria) to present to cytotoxic T lymphocytes (CD8 ϩ T cells) (24) . On the other hand, the MHC II pathway interacts with endocytic exogenous antigens (such as antigens generated from F. novicida ⌬iglB in the phagosomes) for presentation to helper T cells (CD4 ϩ T cells) (24) . Given that the initial priming mechanisms for the two attenuated mutant vaccine strains may be different, we sought to investigate whether these strains utilized different host immune components to induce protection against pulmonary F. tularensis LVS challenge with a panel of knockout mice, including MHC I, MHC II, CD4
ϩ T cells, CD8 ϩ T cells, and perforin, a potent cytotoxic effector molecule produced primarily by CD8 ϩ T cells and natural killer (NK) cells. In these studies, we found an important protective role for perforin following oral F. novicida ⌬fopC but not F. novicida ⌬iglB vaccination against pulmonary F. tularensis LVS infection. The protection conferred by F. novicida ⌬fopC vaccination may be mediated by NK cells via the release of perforin and granzymes. This is the first report that definitively describes dissimilar host-protective mechanisms mediated by two live attenuatedF.novicidavaccinestrainswithmajordifferencesinphagosomal escape phenotypes.
MATERIALS AND METHODS
Bacteria. F. tularensis subsp. novicida strain U112 was provided by Francis Nano (University of Victoria, Victoria, Canada). F. tularensis subsp. holarctica LVS (lot 703-0303-016) was obtained from Rick Lyons (University of New Mexico). The iglB and fopC mutants of F. novicida U112 were generated as reported previously (36, 46) . All strains were grown at 37°C in tryptic soy broth (TSB) or on tryptic soy agar (TSA) (BD Biosciences, San Jose, CA), each supplemented with 0.025% sodium pyruvate, 0.025% sodium metabisulfite, 0.025% ferrous sulfate, and 0.1% L-cysteine. Aliquots of bacteria were stored at Ϫ80°C in TSB containing all supplements and glycerol (24%).
Mice. C57BL/6 mice (4 to 8 weeks) were purchased from the National Cancer Institute (Frederick, MD). C57BL/6 MHC I ␤ 2 -microglobulin (68) , and perforin Ϫ/Ϫ mice (26) were purchased from the Jackson Laboratory (Bar Harbor, ME). Mice were housed and bred at the University of Texas at San Antonio Animal Facility. Animal care and experimental procedures were performed in compliance with Institutional Animal Care and Use Committee (IACUC) guidelines. Experiments were performed with agematched groups of animals.
Immunization and challenge. Mice (5 to 7 animals/group) were anesthetized and orally vaccinated, using a 22-gauge, 25-mm-long, 1.25-mmtip feeding needle (Fine Science Tools Inc., Foster City, CA) (22) Determination of bacterial dissemination of LVS in F. novicida ⌬fopC-and F. novicida ⌬iglB-vaccinated mice. C57BL/6 mice were orally vaccinated with 1,000 CFU of F. novicida ⌬fopC or F. novicida ⌬iglB in 100 l of PBS on day 0 and challenged i.n. with 5 LD 50 of LVS on day 28. Groups of mice (n ϭ 3 per group) were euthanized on days 2 and 5 postchallenge. Lungs, livers, and spleens were removed, and the bacterial counts in the homogenized tissues were determined by dilution plating.
Preparation of single-cell suspensions from spleens. Immunized mice were sacrificed on day 14, and spleens were removed under aseptic conditions, disrupted with a 3 ml syringe plunger, and passed through a 0.76-m cell strainer. Single-cell suspensions were prepared, and erythrocytes were lysed with ammonium chloride. Cells were washed, viability was assessed by trypan blue exclusion, and cells were resuspended in Dulbecco's modified Eagle medium (DMEM; Mediatech, Fairfax, VA) containing 10% (wt/vol) fetal bovine serum (FBS; HyClone, Logan, UT) supplemented with L-glutamine (D10). The T-lymphocytes and NK cells were enriched from single-cell suspensions of splenocytes using an EasySep mouse T cell enrichment kit and an EasySep mouse NK cell enrichment kit (Stemcell Technologies, Vancouver, Canada), respectively. For experiments involving antigen-presenting cells (APCs), splenocytes were treated with mitomycin C (25 g/10 7 cells) for 20 min at 37°C in 5% CO 2 , followed by 2 h of incubation to separate the adherent APCs from nonadherent lymphocytes.
Generation of bone marrow-derived macrophages (BMDM) and in vitro infection. Four-to five-week-old mice were euthanized, and femurs were removed and flushed with D10 supplemented with penicillin (100 U/ml) and streptomycin (100 g/ml). Cells were collected by centrifugation and resuspended in D10 containing 10% culture medium from the L929 hybridoma cell line (6), seeded into 75-cm 2 tissue culture flasks, and incubated at 37°C with 5% CO 2 to allow differentiation into BMDM. Adherent cells were harvested after 6 to 7 days and stained with phycoerythrin (PE)-conjugated CD11b (BD Biosciences), and flow cytometry was used to determine the purity of the cell population. We routinely obtained Ͼ95% CD11b ϩ cells from the preparations. For bacterial infection, BMDM were seeded at 2 ϫ 10 5 /well in sterile 96-well plates in D10 and incubated at 37°C in 5% CO 2 . After 2 h of incubation, Francisella bacteria were diluted from frozen stocks, added to BMDM at a multiplicity of infection (MOI) of 10:1 or 100:1, and incubated for 2 h to allow bacterial uptake. After 3 washes with DMEM, the BMDM were then incubated for 1 h in D10 supplemented with 50 g/ml gentamicin to kill extracellular bacteria. Cells were washed three times and lysed with 0.2% deoxycholate solution (3-h time point) or incubated in D10 for additional 21 h prior to lysis (24-h time point). Intracellular bacteria were enumerated by plating serial dilutions of lysates on TSA containing supplements.
For coculture experiments, T cells or NK cells enriched from splenocytes were added to LVS-infected (10 MOI) BMDM at a 1:1 ratio (200 l/well) following gentamicin treatment. Cultures were incubated at 37°C in 5% CO 2 for the remainder of the experiment. LVS replication within BMDM was determined as described above. Supernatants also were collected for measurement of cytokines and/or granzyme at 3, 6, 12, 24, and/or 72 h based on the specific experimental conditions. IFN-␥, interleukin 1␤ (IL-1␤), and granzyme enzyme-linked immunosorbent assays (ELISAs) (BD Pharmingen, San Diego, CA) were used to determine cytokine levels in the supernatants according to manufacturer's recommendations.
Statistical analysis. Data from all assays were evaluated using an ANOVA one-way test, except that the Kaplan-Meier test was used for survival analysis. The data are presented as means Ϯ standard deviations. Each experiment was independently done at least twice.
RESULTS
F. novicida ⌬fopC but not F. novicida ⌬iglB escaped from phagosomes in primary macrophages. We previously characterized two F. novicida (strain U112) mutants, F. novicida ⌬iglB and F. novicida ⌬fopC, which showed distinctive intramacrophage replication phenotypes (9, 46) . As shown in Fig. 1A , the ⌬iglB strain was attenuated in growth (less than a 1-log-unit increase from 3 h to 24 h after inoculation) in BMDM, whereas the ⌬fopC strain, like its wild-type parent, U112, displayed marked replication (3-to 4-log-unit increase). Lack of intracellular replication forFrancisella⌬iglBhasbeencorrelatedwithitsdeficiencyinphago-somal escape (7). To assess whether F. novicida ⌬fopC escaped from phagosomes and replicated in the cytosol, as seen with the U112 parental strain (57, 58), we analyzed IL-1␤ secretion by BMDM following bacterial infection. Release of IL-1␤ in infected macrophages as a result of inflammasome activation following escape of Francisella from the phagosome into the cytosol has been reported (8, 20, 21, 41) . We observed a comparable high level (Ͼ3,000 pg/ml) of IL-1␤ released by BMDM upon live U112 and F. novicida ⌬fopC infection but not with UV-inactivated bacteria (data not shown), suggesting escape of live F. novicida ⌬fopC cells from phagosomes (Fig. 1B) . In contrast, minimal amounts of IL-1␤ secreted by F. novicida ⌬iglB-infected BMDM confirmed that F. novicida ⌬iglB failed to disrupt phagosomes, similarly to other reported FPI-associated mutants (58, 59) . Negligible amounts of IL-1␤ were secreted by uninfected macrophages (Fig.  1B) as well as those infected with UV-inactivated bacteria (data not shown). Collectively, such evidence indicates differences in the cytosolic presence and replication between the F. novicida ⌬iglB and F. novicida ⌬fopC strains, which might lead to some distinct immune responses due to differences in antigen processing and presentation by the host cells.
Antigen presentation by APC following F. novicida ⌬fopC and F. novicida ⌬iglB infection. Gene knockout (KO) mice with deficient MHC I or MHC II were used to study whether different pathways were used to present F. novicida ⌬fopC and F. novicida ⌬iglB antigens. APCs were generated from naïve wild-type (WT), MHC I KO, and MHC II KO mice by treating the total splenocyte population with mitomycin C, followed by removal of nonadherent cells. APCs (2 ϫ 10 5 /well) were then infected (MOI of 10) with live or UV-inactivated F. novicida ⌬fopC or F. novicida ⌬iglB for 2 h, treated with gentamicin for an additional 1 h, and then washed to remove all extracellular bacteria. These antigen-loaded APCs were incubated for 72 h with T-lymphocytes enriched from spleens of WT mice which had been inoculated orally with 1,000 CFU of F. novicida ⌬fopC, F. novicida ⌬iglB, or PBS. Following incubation, IFN-␥ concentrations in the culture supernatants were assayed, and these served as an indicator of T-cell activation by the APCs.
As shown in Fig. 2 , T cells from PBS-treated (mock-vaccinated) mice, regardless of whether they were cocultured with APCs isolated from WT, MHC I KO, or MHC II KO mice and previously infected with F. novicida ⌬fopC, F. novicida ⌬iglB, or hen egg lysozyme (HEL, an unrelated antigen used as a control), had minimal IFN-␥ induction, as expected. In contrast, T cells obtained from WT mice primed by oral vaccination with F. novi-
FIG 1 Phenotypic differences between F. novicida ⌬iglB and F. novicida ⌬fopC
in bacterial replication and IL-1␤ production in BMDM. BMDM were infected (MOI, 10 or 100) with WT U112, F. novicida ⌬fopC, or F. novicida ⌬iglB. (A) Cell lysates were dilution plated at 3 and 24 h postinfection for bacterial enumeration. Differences in bacterial numbers were significant (*, P Ͻ 0.05; **, P Ͻ 0.01) for F. novicida ⌬iglB compared to U112 or F. novicida ⌬fopC at 24 h at MOIs of 10 and 100. (B) Supernatants were collected at 6, 12, and 24 h postinfection for determination of IL-1␤ levels by ELISA. Differences in IL-1␤ production at 12 and 24 h between F. novicida ⌬iglB and either U112 or F. novicida ⌬fopC were significant (***, P Ͻ 0.001). Results are representative of three independent experiments with triplicates in each group. cida ⌬fopC or F. novicida ⌬iglB, upon incubation with WT APCs infected with respective bacterial mutant strains, exhibited similar elevated levels of IFN-␥ production, indicating that WT APCs effectively processed and presented both F. novicida ⌬fopC and F. novicida ⌬iglB antigens. Similarly, comparable IFN-␥ levels were observed in T cells primed with F. novicida ⌬fopC and F. novicida ⌬iglB, upon activation by respective mutant-infected APCs from either MHC I or MHC II KO mice, although levels for both mutants were lower in MHC II KO mice. Additionally, there was no significant difference in IFN-␥ production by primed T cells upon activation by either live or UV-inactivated mutant-infected APCs from WT, MHC I Ϫ/Ϫ , or MHC II Ϫ/Ϫ mice. Collectively, these data suggest that there may be cross antigen presentation of the two mutant strains by MHC I and II pathways.
Roles of CD4 ؉ and CD8 ؉ T cells in F. novicida ⌬fopC and F. novicida ⌬iglB oral vaccination-mediated protection against intranasal LVS challenge. In the ex vivo system described above, we observed no difference in antigen processing and presentation by major MHC pathways following F. novicida ⌬fopC and F. novicida ⌬iglB uptake by APCs. Thus, we then determined whether CD4 ϩ and CD8 ϩ T cells played comparable roles in F. novicida ⌬fopC and F. novicida ⌬iglB vaccination-mediated protection.
Mice (WT, CD4
Ϫ/Ϫ , and CD8 Ϫ/Ϫ ) were vaccinated orally with F. novicida ⌬fopC, F. novicida ⌬iglB, or PBS and challenged i.n. with a lethal dose (5 LD 50 ) of LVS on day 28. Organs (lungs, livers, and spleens) were collected on days 2 and 5 postchallenge and homogenized to determine bacterial burdens. In mock-vaccinated mice, although there was 1 log unit less LVS in the spleens of CD4 Ϫ/Ϫ
and CD8
Ϫ/Ϫ mice than in those of WT mice, we observed no significant difference in mortality among these three groups of mice following a lethal LVS challenge (all mice succumbed to infection by day 10 [data not shown]), which may have been due to the relatively high LVS burdens in the target organs that led to uncontrolled inflammation and death (40, 73) . In contrast, all mice (WT, CD4
Ϫ/Ϫ , and CD8 Ϫ/Ϫ ) vaccinated with either F. novicida ⌬fopC or F. novicida ⌬iglB had significantly reduced LVS burdens on days 2 and 5 in the primary challenge site (lungs) and in secondary targeted organs (livers and spleens) compared to mock-vaccinated mice (Fig. 3) . However, in CD8 Ϫ/Ϫ mice, greater bacterial burdens were evident in the lungs and livers of F. novicida ⌬fopC-vaccinated mice than F. novicida ⌬iglB-immunized mice, and the increased organ burdens correlated with reduced survival rate (66.7% for F. novicida ⌬fopC immunization versus 100% for F. novicida ⌬iglB immunization [data not shown]), suggesting that the CD8 component may be required for F. novicida ⌬fopC-but not F. novicida ⌬iglB-mediated protection against LVS challenge.
Perforin is required for F. novicida ⌬fopC-mediated protection against LVS challenge. Given that CD8 ϩ T cells may control LVS infection in F. novicida ⌬fopC-vaccinated mice and perforin is a key effector of CD8 ϩ cell granule-mediated cytotoxicity (26, 33), we sought to determine the role of perforin in inducing protective immunity following oral F. novicida ⌬fopC vaccination. WT and perforin KO (PRF Ϫ/Ϫ ) mice were vaccinated with F. novicida ⌬fopC, F. novicida ⌬iglB, or PBS and challenged i.n. with 5 LD 50 of LVS on day 30. Bacterial burdens in the lungs, livers, and spleens were measured at days 2 and 5 after LVS challenge, and survival was monitored for 30 days. We observed consistently high LVS burdens in all organs of PBS control WT mice at day 2 postchallenge ( Fig. 3 and 4) , which might be due to the high challenge inoculum (38,000 to 44,000 CFU) used as described in Materials and Methods. Vaccination of WT mice with either F. novicida ⌬fopC or F. novicida ⌬iglB resulted in significant reductions of LVS in all target organs compared to mock-vaccinated mice (Fig.  4, top) . In contrast, while PRF Ϫ/Ϫ mice retained their ability to control LVS growth effectively when vaccinated with F. novicida ⌬iglB, the deficiency in perforin abrogated the reduction of LVS burdens mediated by F. novicida ⌬fopC immunization, resulting in organ burdens as high as those in the mock-vaccinated animals (Fig. 4, bottom) . Although no significant increase of LVS burdens from day 2 to day 5 was observed in target organs of F. novicida
FIG 3 Role of CD4
ϩ and CD8 ϩ T cells in F. novicida ⌬fopC-and F. novicida ⌬iglB-mediated protection (bacterial burden) against intranasal LVS challenge. Mice (3 per time point) were vaccinated orally with 1,000 CFU of F. novicida ⌬fopC or F. novicida ⌬iglB or mock treated with PBS on day 0 and i.n. challenged with a lethal dose of LVS (44,000 CFU, ϳ5 LD 50 ) on day 28. Lungs, livers, and spleens were collected on days 2 and 5 after LVS challenge to determine the bacterial burdens. Significant differences in LVS burdens on day 2 and day 5 in three tested organs from either F. novicida ⌬fopC-or F. novicida ⌬iglB-vaccinated mice, compared to those in mock-vaccinated mice, are indicated (*, P Ͻ 0.05; **, P Ͻ 0.01; ***P Ͻ 0.001). The difference in LVS burdens in the lungs and livers between F. novicida ⌬fopC-and F. novicida ⌬iglB-vaccinated CD8 Ϫ/Ϫ mice was also significant (*, P Ͻ 0.05; ***, P Ͻ 0.001). Results are representative of two independent experiments.
⌬fopC-vaccinated PRF
Ϫ/Ϫ mice, high levels of bacterial burden correlated with high mortality (67%) of these perforin-deficient mice following lethal LVS challenge, compared to a 17% mortality rate in the F. novicida ⌬fopC-vaccinated WT mice (Fig. 5) . These results suggest that perforin plays an important role in F. novicida ⌬fopC-mediated protective immunity against LVS infection. There was no difference in survival between F. novicida ⌬iglB-immunized, LVS-challenged WT and PRF Ϫ/Ϫ mice, suggesting that while perforin is essential for F. novicida ⌬fopC-mediated protection, it has a minimal role in F. novicida ⌬iglB-generated protective immunity.
Perforin plays an important role in T-cell-and NK cell-mediated inhibition of LVS intramacrophage replication. Cytotoxic T lymphocytes and NK cells are the major cell types that produce perforin upon activation (42, 61) . To dissect the potential mechanism of perforin in control of LVS infection in F. novicida ⌬fopC-vaccinated mice, we applied an in vitro killing coculture system to compare the inhibition of LVS intramacrophage replication in perforin competent and deficient T cells and NK cells. Total T cells were enriched from spleens of either F. novicida ⌬fopC-or mock-immunized WT or PRF Ϫ/Ϫ mice and cocultured for 21 h with WT BMDM which had previously been infected with LVS (2-h infection and 1-h gentamicin treatment). The levels of viable LVS within the BMDM were determined, and the production of granzymes, proteases delivered by perforin which trigger apoptosis of target cells (10) , as well as IFN-␥, a potent cytokine produced by T cells that controls Francisella replication (2, 13, 46, 48) , were measured in the culture supernatant at the end of coculture. LVS increased by 3 log units from 3 to 24 h in BMDM that were cultured alone (Fig. 6A) . In contrast, there was a 25-fold (1.4-log-unit) reduction of LVS replication in BMDM cocultured with F. novicida ⌬fopC-primed WT T cells (a 1.6-log-unit increase from 3 h to 24 h) compared to WT PBS-treated T cells (3-log-unit increase from 3 h to 24 h). BMDM cocultured with LVS WT F. novicida ⌬fopC-primed PRF Ϫ/Ϫ T cells exhibited only a 3-fold (0.5-log-unit) inhibition of LVS replication, suggesting that perforin played an important role in control of LVS intracellular replication. Granzyme levels were markedly higher in WT, F. novicida ⌬fopC-vaccinated T cells cocultured with LVS-infected BMDM than the minimal granzymes produced by PRF Ϫ/Ϫ F. novicida ⌬fopC-primed T cells (Fig. 6B) . On the other hand, comparable high levels of IFN-␥ were produced by both WT and PRF Ϫ/Ϫ F. novicida ⌬fopC-primed T cells (Fig. 6C) , suggesting that perforinmediated inhibition of LVS replication in BMDM cells may be IFN-␥ independent but granzyme dependent. Since CD8 ϩ cells are the most predominate perforin-secreting T-cell type and PRFmediated bacterial clearance was evident in our total T-cell population, a role of CD8 ϩ cells in PRF-mediated bacterial clearance in F. novicida ⌬fopC-vaccinated mice seems likely.
Similar results were observed in LVS-infected BMDM cocultured with NK cells enriched from spleens of naïve WT and PRF Ϫ/Ϫ mice. Replication of LVS within BMDM over a period of 24 h was markedly decreased in the presence of WT NK cells but not PRF Ϫ/Ϫ NK cells, suggesting that NK cell-mediated LVS killing required perforin (Fig. 7A, left) . This NK cell-mediated LVS killing could be further enhanced by preincubation of NK cells with F. novicida ⌬fopC immune sera (Fig. 7A, right) . In these experiments, NK cells were incubated with serum from mockimmunized or F. novicida ⌬fopC-immunized mice (1:20 dilution) for 20 min before coculture with BMDM. As shown in Fig. 7A , WT NK cells incubated with sera from PBS-treated mice significantly reduced LVS replication in BMDM compared to non-serum- Ϫ/Ϫ mice were vaccinated orally with 1,000 CFU of F. novicida ⌬fopC or F. novicida ⌬iglB or mock treated with PBS on day 0 and i.n. challenged with a lethal dose of LVS (38,000 CFU, ϳ5 LD 50 ) on day 28. Lungs, livers and spleens (3 mice per time point) were collected on days 2 and 5 after LVS challenge to determine the bacterial burdens. In WT mice (top), the difference in LVS burdens in all organs between PBS and mutant (F. novicida ⌬fopC or F. novicida ⌬iglB)-vaccinated mice were significant (P Ͻ 0.001). In PRF Ϫ/Ϫ mice (bottom), LVS burdens were significantly (P Ͻ 0.001) reduced only when mice were vaccinated with F. novicida ⌬iglB, not F. novicida ⌬fopC, compared to PBS treatment. Results are representative of two independent experiments. 3 CFU/well at 24 h). Deletion of perforin totally abrogated NK cell-mediated LVS killing even in the presence of F. novicida ⌬fopC immune sera (Fig. 7A, right) . Similar to T cells, NK cell perforin-mediated LVS killing was associated with granzyme secretion and was independent of IFN-␥ production ( Fig. 7B and C) .
Collectively, our data suggest that perforin-and granzymemediated control of LVS replication in macrophages by T and NK cells is one of the mediators of the immune response against F. tularensis infection induced by F. novicida ⌬fopC vaccination.
Inhibition of LVS replication in BMDM by NK cells is mediated via an antibody-dependent cellular cytotoxicity pathway. F. novicida ⌬fopC-immune sera appeared to play an important role in enhancing the cytotoxic activity of NK cells in control of LVS replication. NK cells express an activating Fc receptor (Fc␥RIIIa) that mediates antibody-dependent cellular cytotoxicity (ADCC) and production of immune-modulatory cytokines in response to antibody-coated targets (67, 68) . To confirm that ADCC was indeed employed by NK cells in the killing of F. tularensis, we compared LVS replication in BMDM cocultured with NK cells isolated from WT mice and from Fc␥R Ϫ/Ϫ mice (68), which are deficient in Fc␥RI and Fc␥RIII. We observed that LVS replication increased the number of organisms by about 3 log units in BMDM from 3 to 24 h, in contrast to almost no viable LVS increase in BMDM cocultured with WT NK cells pretreated with F. novicida ⌬fopC-immune serum. However, this marked LVS inhibition was completely abrogated by coculture with Fc␥R Ϫ/Ϫ NK cells (Fig. 8A) . High levels of both granzyme (Fig. 8B ) and IFN-␥ (Fig. 8C ) secretion in coculture of BMDM with NK cells coincided with marked LVS inhibition by the WT NK cells. Additionally, a significant reduction of granzyme (Fig. 8B ) and IFN-␥ (Fig. 8C ) production was found in infected BMDM cocultured with Fc␥R Ϫ/Ϫ NK cells compared to those cultured with WT NK cells, suggesting that both IFN-␥ and granzymes may be involved in NK cell Fc␥R receptor-mediated LVS killing. Collectively, these results further demonstrate that NK cells employ ADCC in control of LVS infection. 
DISCUSSION
In this study, we showed that the two live attenuated F. novicida mutant strains, F. novicida ⌬fopC and F. novicida ⌬iglB, utilize different host immune components to induce protection against pulmonary Francisella LVS challenge. Specifically, we demonstrated that perforin may play an essential role in F. novicida ⌬fopC-mediated immunity but is dispensable for F. novicida ⌬iglB-mediated protection against LVS infection. These analyses provide additional insight into effector components that induce protective immune responses against pulmonary tularemia.
Despite the significant differences in phagosomal escape and cytosolic bacterial replication, antigenic epitopes of F. novicida ⌬fopC and F. novicida ⌬iglB seem to be processed and presented by APCs using both MHC I and MHC II pathways. In the case of F. novicida ⌬fopC, the bacterium escapes from phagosomes, replicates in the cytosol, and stimulates IL-1␤, but it also is susceptible to phagolysis upon activation of IFN-␥ (46) . This may explain the presentation of F. novicida ⌬fopC epitopes by both MHC I and II pathways. In contrast, small numbers of F. novicida ⌬iglB may escape and replicate in the cytosol, accounting for the minimal increase in bacterial replication after 24 h within primary macrophages. However, cross-presentation of exogenous (F. novicida ⌬iglB) antigens by MHC I is also possible using cellular mechanisms, as reviewed by Ackerman and Cresswell (1) . One such mechanism is based on endoplasmic reticulum-mediated phagocytosis. The MHC I peptide-loading complex is recruited to phagosomes, along with a Sec61 pore complex by which phagocytosed exogenous proteins are shuttled into the cytosol, and proteolysed by the proteasome, and the generated antigenic peptides are then loaded onto the MHC I complex and presented to CD8 ϩ T cells (19, 72) . In support of cross-presentation, oral vaccination of WT mice with F. novicida ⌬fopC and F. novicida ⌬iglB resulted in comparable serum anti-LVS IgG titers (S. Sanapala and B. P. Arulanandam, unpublished observations) and similar survival rates following pulmonary LVS challenge. Additionally, comparable antigen-specific cell-mediated immune responses were induced following oral immunization with F. novicida ⌬fopC and F. novicida ⌬iglB, as seen by elevated IFN-␥ produced by F. novicida ⌬fopC-or F. novicida ⌬iglB-primed T cells upon cellular recall with UV-inactivated LVS (Sanapala and Arulanandam, unpublished).
Cytotoxic T lymphocytes and NK cells may employ several mechanisms to clear intracellular bacteria, including cytokine release (15), induction of apoptosis of the host cell (27) , and antimicrobial activity (64) . In this regard, IFN-␥ is essential for control of F. tularensis infection, and NK cells are important producers of IFN-␥ during primary LVS infection in the lungs and liver (5, 37); however, the role of cytolytic activity of NK cells in control of Francisella infection is largely unknown. We show here that perforin-deficient NK cells are impaired in effective inhibition of LVS replication in macrophages. Perforin was originally thought to cause cell lysis by forming pores on the target cell membrane (51), but later studies favor the theory that perforin functions by enabling granzymes to escape from the endosomes into the cytosol of the target cell (45, 50) , where the granzymes trigger caspase activation and lead to cell apoptosis. In addition to mediating the cell death pathway, the internal peptide of granzyme B (HPAYNPK) displays bactericidal action in vitro, suggesting the possibility of antibacterial activities (60) . In this study, we observed minimal production of granzymes by PRF Ϫ/Ϫ T cells and NK cells upon coincubation with LVS-infected BMDM along with the loss of the ability to control LVS replication, further suggesting a granzyme-dependent mechanism in perforin-mediated protection. This was supported by the observation of greater bacterial dissemination and reduced survival rates in F. novicida ⌬fopC-vaccinated PRF Ϫ/Ϫ mice than was observed following F. novicida ⌬iglB immunization or in F. novicida ⌬fopC-vaccinated WT mice. Thus, CD8
ϩ T cells and NK cells may play a greater role in F. novicida ⌬fopC-mediated protection against LVS challenge than in protection mediated by F. novicida ⌬iglB, and this likely occurs through cytolysis-induced mechanisms. CD8 ϩ T cell perforinmediated cytotoxicity also has been reported to play a role in control of other intracellular bacteria, such as Listeria monocytogenes and Mycobacterium tuberculosis (25, 63) .
Of note, optimal control of LVS replication in BMDM by NK cells via perforin release was achieved in the presence of anti-F. novicida ⌬fopC sera and was dependent on Fc␥R receptor-mediated signaling. The importance of antibody in F. novicida ⌬fopC-mediated protection is further supported by the increased suscep- tibility to pulmonary LVS challenge in F. novicida ⌬fopC-vaccinated B-cell-deficient mice (50% survival rate [Sanapala and Arulanandam, unpublished]) compared to wild-type mice (100% survival). Antibody-mediated protection against F. tularensis also has been reported by us (48, 52, 54) and others (16, 17, 28, 65) , showing that adoptive transfer of anti-F. novicida mutant, anti-LVS, or anti-Francisella LPS antibodies conferred partial protection against LVS and type B Francisella challenge. Using genetically deficient mice, Kirimanjeswara et al. (28) further demonstrated that Fc␥R-mediated opsonophagocytosis plays an important role in antibody-mediated protection against i.n. LVS lethal challenge. Thus, specific antibodies generated by F. novicida ⌬fopC immunization may contribute to the control of LVS infection both by facilitating LVS uptake via Fc␥R-mediated opsonophagocytosis into APCs and by LVS killing via Fc␥R-dependent ADCC by NK cells.
Taken together, results of our study suggest that perforin-and granzyme-mediated cytotoxic effector functions are essential for protective immunity against F. tularensis following F. novicida ⌬fopC vaccination.
